| Counting costs of care |
| JC McVie |
|
JCO Oct 1 1988: 1529–1531.
[PDF]
|
 |
| Allogeneic transplantation versus intensive chemotherapy in first- remission acute leukemia: is there a "best choice"? |
| RJ Mayer |
|
JCO Oct 1 1988: 1532–1536.
[PDF]
|
|
|
Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer |
| |
PJ Goodwin, R Feld, WK Evans, and J Pater |
| |
JCO Oct 1 1988: 1537–1547.
[Abstract]
[PDF]
|
|
|
A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission |
| |
AR Zander, M Keating, K Dicke, D Dixon, S Pierce, S Jagannath, L Peters, L Horwitz, K Cockerill, and G Spitzer |
| |
JCO Oct 1 1988: 1548–1557.
[Abstract]
[PDF]
|
|
|
Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease |
| |
RB Geller, GB Vogelsang, JR Wingard, AM Yeager, WH Burns, GW Santos, and R Saral |
| |
JCO Oct 1 1988: 1558–1561.
[Abstract]
[PDF]
|
|
|
Regimen-related toxicity in patients undergoing bone marrow transplantation |
| |
SI Bearman, FR Appelbaum, CD Buckner, FB Petersen, LD Fisher, RA Clift, and ED Thomas |
| |
JCO Oct 1 1988: 1562–1568.
[Abstract]
[PDF]
|
|
|
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy |
| |
M Shtalrid, M Talpaz, M Blick, P Romero, H Kantarjian, K Taylor, J Trujillo, J Schachner, JU Gutterman, and R Kurzrock |
| |
JCO Oct 1 1988: 1569–1575.
[Abstract]
[PDF]
|
|
|
Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation |
| |
P Mauch, N Tarbell, H Weinstein, B Silver, T Goffman, R Osteen, A Zajac, CN Coleman, G Canellos, and D Rosenthal |
| |
JCO Oct 1 1988: 1576–1583.
[Abstract]
[PDF]
|
|
|
T-cell lymphomas: immunologic, histologic, clinical, and therapeutic analysis of 63 cases |
| |
B Coiffier, F Berger, PA Bryon, and JP Magaud |
| |
JCO Oct 1 1988: 1584–1589.
[Abstract]
[PDF]
|
|
|
Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update |
| |
CJ Logothetis, DE Johnson, C Chong, FH Dexeus, A Sella, S Ogden, T Smith, DA Swanson, RJ Babaian, and KI Wishnow |
| |
JCO Oct 1 1988: 1590–1596.
[Abstract]
[PDF]
|
|
|
Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance |
| |
PI Thompson, J Nixon, and VJ Harvey |
| |
JCO Oct 1 1988: 1597–1603.
[Abstract]
[PDF]
|
|
|
Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation |
| |
RA Figlin, JB deKernion, E Mukamel, AV Palleroni, LM Itri, and GP Sarna |
| |
JCO Oct 1 1988: 1604–1610.
[Abstract]
[PDF]
|
|
|
A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma |
| |
JM Bennett, HB Muss, JH Doroshow, S Wolff, ET Krementz, K Cartwright, G Dukart, A Reisman, and I Schoch |
| |
JCO Oct 1 1988: 1611–1620.
[Abstract]
[PDF]
|
|
|
Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis |
| |
N Cohen, G Strauss, R Lew, D Silver, and L Recht |
| |
JCO Oct 1 1988: 1621–1624.
[Abstract]
[PDF]
|
|
|
Reoperation for brain metastases |
| |
N Sundaresan, VP Sachdev, GV DiGiacinto, and JE Hughes |
| |
JCO Oct 1 1988: 1625–1629.
[Abstract]
[PDF]
|
|
|
Reduced therapy for Wilms' tumor: analysis of treatment results from a single institution |
| |
JA Wilimas, EC Douglass, S Lewis, D Fairclough, G Fullen, D Parham, AP Kumar, HO Hustu, and I Fleming |
| |
JCO Oct 1 1988: 1630–1635.
[Abstract]
[PDF]
|
|
|
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites |
| |
S Vadhan-Raj, C Cordon-Cardo, E Carswell, D Mintzer, L Dantis, C Duteau, MA Templeton, HF Oettgen, LJ Old, and AN Houghton |
| |
JCO Oct 1 1988: 1636–1648.
[Abstract]
[PDF]
|
|
|
Keeping up with the cancer literature--PDQ ACCESS |
| |
DJ Perry, EM Sloane, SM Hubbard, DE Tingley, and VT DeVita |
| |
JCO Oct 1 1988: 1649–1652.
[Abstract]
[PDF]
|
|
|
Fluorouracil: biochemistry and pharmacology |
| |
HM Pinedo and GF Peters |
| |
JCO Oct 1 1988: 1653–1664.
[Abstract]
[PDF]
|
|
| Splenectomy for Hodgkin's disease |
| R Kuse |
|
JCO Oct 1 1988: 1665a.
[PDF]
|
|
| Chemotherapy of advanced breast cancer |
| R Herrmann |
|
JCO Oct 1 1988: 1665b–1666.
[PDF]
|
|
| Dose-dependent effect of AHPrBP in malignant hypercalcemia: wishful thinking and facts |
| D Thiebaud and P Burckhardt |
|
JCO Oct 1 1988: 1666–1667.
[PDF]
|
|
